The Market Reports

Index

1 Levonorgestrel API Market Overview
1.1 Product Overview and Scope of Levonorgestrel API
1.2 Levonorgestrel API Segment by Type
1.2.1 Global Levonorgestrel API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Short-Acting Contraceptive API
1.2.3 Long-Acting Contraceptive API
1.3 Levonorgestrel API Segment by Application
1.3.1 Global Levonorgestrel API Sales Comparison by Application: (2021-2027)
1.3.2 Levonorgestrel Tablet
1.3.3 Mixture Products
1.3.4 Hormone-releasing IUD
1.4 Global Levonorgestrel API Market Size Estimates and Forecasts
1.4.1 Global Levonorgestrel API Revenue 2016-2027
1.4.2 Global Levonorgestrel API Sales 2016-2027
1.4.3 Levonorgestrel API Market Size by Region: 2016 Versus 2021 Versus 2027

2 Levonorgestrel API Market Competition by Manufacturers
2.1 Global Levonorgestrel API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Levonorgestrel API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Levonorgestrel API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Levonorgestrel API Manufacturing Sites, Area Served, Product Type
2.5 Levonorgestrel API Market Competitive Situation and Trends
2.5.1 Levonorgestrel API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Levonorgestrel API Players Market Share by Revenue
2.5.3 Global Levonorgestrel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Levonorgestrel API Retrospective Market Scenario by Region
3.1 Global Levonorgestrel API Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Levonorgestrel API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Levonorgestrel API Market Facts & Figures by Country
3.3.1 North America Levonorgestrel API Sales by Country
3.3.2 North America Levonorgestrel API Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Levonorgestrel API Market Facts & Figures by Country
3.4.1 Europe Levonorgestrel API Sales by Country
3.4.2 Europe Levonorgestrel API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Levonorgestrel API Market Facts & Figures by Region
3.5.1 Asia Pacific Levonorgestrel API Sales by Region
3.5.2 Asia Pacific Levonorgestrel API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Levonorgestrel API Market Facts & Figures by Country
3.6.1 Latin America Levonorgestrel API Sales by Country
3.6.2 Latin America Levonorgestrel API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Levonorgestrel API Market Facts & Figures by Country
3.7.1 Middle East and Africa Levonorgestrel API Sales by Country
3.7.2 Middle East and Africa Levonorgestrel API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Levonorgestrel API Historic Market Analysis by Type
4.1 Global Levonorgestrel API Sales Market Share by Type (2016-2021)
4.2 Global Levonorgestrel API Revenue Market Share by Type (2016-2021)
4.3 Global Levonorgestrel API Price by Type (2016-2021)

5 Global Levonorgestrel API Historic Market Analysis by Application
5.1 Global Levonorgestrel API Sales Market Share by Application (2016-2021)
5.2 Global Levonorgestrel API Revenue Market Share by Application (2016-2021)
5.3 Global Levonorgestrel API Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bayer HealthCare
6.1.1 Bayer HealthCare Corporation Information
6.1.2 Bayer HealthCare Description and Business Overview
6.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer HealthCare Levonorgestrel API Product Portfolio
6.1.5 Bayer HealthCare Recent Developments/Updates
6.2 Qinhuangdao Zizhu Pharmaceutical
6.2.1 Qinhuangdao Zizhu Pharmaceutical Corporation Information
6.2.2 Qinhuangdao Zizhu Pharmaceutical Description and Business Overview
6.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Portfolio
6.2.5 Qinhuangdao Zizhu Pharmaceutical Recent Developments/Updates
6.3 Yangzhou Pharmaceutical
6.3.1 Yangzhou Pharmaceutical Corporation Information
6.3.2 Yangzhou Pharmaceutical Description and Business Overview
6.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Yangzhou Pharmaceutical Levonorgestrel API Product Portfolio
6.3.5 Yangzhou Pharmaceutical Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Corporation Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lupin Levonorgestrel API Product Portfolio
6.4.5 Lupin Recent Developments/Updates
6.5 Hubei Gedian Humanwell
6.5.1 Hubei Gedian Humanwell Corporation Information
6.5.2 Hubei Gedian Humanwell Description and Business Overview
6.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hubei Gedian Humanwell Levonorgestrel API Product Portfolio
6.5.5 Hubei Gedian Humanwell Recent Developments/Updates
6.6 Sterling Spa
6.6.1 Sterling Spa Corporation Information
6.6.2 Sterling Spa Description and Business Overview
6.6.3 Sterling Spa Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sterling Spa Levonorgestrel API Product Portfolio
6.6.5 Sterling Spa Recent Developments/Updates
6.7 Formos
6.6.1 Formos Corporation Information
6.6.2 Formos Description and Business Overview
6.6.3 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Formos Levonorgestrel API Product Portfolio
6.7.5 Formos Recent Developments/Updates
6.8 Huazhong Pharm
6.8.1 Huazhong Pharm Corporation Information
6.8.2 Huazhong Pharm Description and Business Overview
6.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Huazhong Pharm Levonorgestrel API Product Portfolio
6.8.5 Huazhong Pharm Recent Developments/Updates
6.9 ASG Biochem
6.9.1 ASG Biochem Corporation Information
6.9.2 ASG Biochem Description and Business Overview
6.9.3 ASG Biochem Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ASG Biochem Levonorgestrel API Product Portfolio
6.9.5 ASG Biochem Recent Developments/Updates

7 Levonorgestrel API Manufacturing Cost Analysis
7.1 Levonorgestrel API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Levonorgestrel API
7.4 Levonorgestrel API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Levonorgestrel API Distributors List
8.3 Levonorgestrel API Customers

9 Levonorgestrel API Market Dynamics
9.1 Levonorgestrel API Industry Trends
9.2 Levonorgestrel API Growth Drivers
9.3 Levonorgestrel API Market Challenges
9.4 Levonorgestrel API Market Restraints

10 Global Market Forecast
10.1 Levonorgestrel API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Levonorgestrel API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Levonorgestrel API by Type (2022-2027)
10.2 Levonorgestrel API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Levonorgestrel API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Levonorgestrel API by Application (2022-2027)
10.3 Levonorgestrel API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Levonorgestrel API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Levonorgestrel API by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Levonorgestrel API Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Levonorgestrel API Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Levonorgestrel API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Levonorgestrel API Covered in This Study
Table 5. Global Levonorgestrel API Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Levonorgestrel API Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Levonorgestrel API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Levonorgestrel API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Levonorgestrel API Average Price (USD/KG) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Levonorgestrel API Manufacturing Sites and Area Served
Table 11. Manufacturers Levonorgestrel API Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Levonorgestrel API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levonorgestrel API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Levonorgestrel API Sales by Region (2016-2021) & (Kg)
Table 16. Global Levonorgestrel API Sales Market Share by Region (2016-2021)
Table 17. Global Levonorgestrel API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Levonorgestrel API Sales by Country (2016-2021) & (Kg)
Table 19. North America Levonorgestrel API Sales Market Share by Country (2016-2021)
Table 20. North America Levonorgestrel API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Levonorgestrel API Revenue Market Share by Country (2016-2021)
Table 22. Europe Levonorgestrel API Sales by Country (2016-2021) & (Kg)
Table 23. Europe Levonorgestrel API Sales Market Share by Country (2016-2021)
Table 24. Europe Levonorgestrel API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Levonorgestrel API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Levonorgestrel API Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Levonorgestrel API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Levonorgestrel API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Levonorgestrel API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Levonorgestrel API Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Levonorgestrel API Sales Market Share by Country (2016-2021)
Table 32. Latin America Levonorgestrel API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Levonorgestrel API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Levonorgestrel API Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Levonorgestrel API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Levonorgestrel API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Levonorgestrel API Revenue Market Share by Country (2016-2021)
Table 38. Global Levonorgestrel API Sales (Kg) by Type (2016-2021)
Table 39. Global Levonorgestrel API Sales Market Share by Type (2016-2021)
Table 40. Global Levonorgestrel API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Levonorgestrel API Revenue Share by Type (2016-2021)
Table 42. Global Levonorgestrel API Price (USD/KG) by Type (2016-2021)
Table 43. Global Levonorgestrel API Sales (Kg) by Application (2016-2021)
Table 44. Global Levonorgestrel API Sales Market Share by Application (2016-2021)
Table 45. Global Levonorgestrel API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Levonorgestrel API Revenue Share by Application (2016-2021)
Table 47. Global Levonorgestrel API Price (USD/KG) by Application (2016-2021)
Table 48. Bayer HealthCare Corporation Information
Table 49. Bayer HealthCare Description and Business Overview
Table 50. Bayer HealthCare Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 51. Bayer HealthCare Levonorgestrel API Product
Table 52. Bayer HealthCare Recent Developments/Updates
Table 53. Qinhuangdao Zizhu Pharmaceutical Corporation Information
Table 54. Qinhuangdao Zizhu Pharmaceutical Description and Business Overview
Table 55. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 56. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product
Table 57. Qinhuangdao Zizhu Pharmaceutical Recent Developments/Updates
Table 58. Yangzhou Pharmaceutical Corporation Information
Table 59. Yangzhou Pharmaceutical Description and Business Overview
Table 60. Yangzhou Pharmaceutical Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 61. Yangzhou Pharmaceutical Levonorgestrel API Product
Table 62. Yangzhou Pharmaceutical Recent Developments/Updates
Table 63. Lupin Corporation Information
Table 64. Lupin Description and Business Overview
Table 65. Lupin Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 66. Lupin Levonorgestrel API Product
Table 67. Lupin Recent Developments/Updates
Table 68. Hubei Gedian Humanwell Corporation Information
Table 69. Hubei Gedian Humanwell Description and Business Overview
Table 70. Hubei Gedian Humanwell Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 71. Hubei Gedian Humanwell Levonorgestrel API Product
Table 72. Hubei Gedian Humanwell Recent Developments/Updates
Table 73. Sterling Spa Corporation Information
Table 74. Sterling Spa Description and Business Overview
Table 75. Sterling Spa Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 76. Sterling Spa Levonorgestrel API Product
Table 77. Sterling Spa Recent Developments/Updates
Table 78. Formos Corporation Information
Table 79. Formos Description and Business Overview
Table 80. Formos Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 81. Formos Levonorgestrel API Product
Table 82. Formos Recent Developments/Updates
Table 83. Huazhong Pharm Corporation Information
Table 84. Huazhong Pharm Description and Business Overview
Table 85. Huazhong Pharm Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 86. Huazhong Pharm Levonorgestrel API Product
Table 87. Huazhong Pharm Recent Developments/Updates
Table 88. ASG Biochem Corporation Information
Table 89. ASG Biochem Description and Business Overview
Table 90. ASG Biochem Levonorgestrel API Sales (Kg), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 91. ASG Biochem Levonorgestrel API Product
Table 92. ASG Biochem Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Levonorgestrel API Distributors List
Table 96. Levonorgestrel API Customers List
Table 97. Levonorgestrel API Market Trends
Table 98. Levonorgestrel API Growth Drivers
Table 99. Levonorgestrel API Market Challenges
Table 100. Levonorgestrel API Market Restraints
Table 101. Global Levonorgestrel API Sales Forecast by Type (2022-2027) & (Kg)
Table 102. Global Levonorgestrel API Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Levonorgestrel API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Levonorgestrel API Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Levonorgestrel API Sales Forecast by Application (2022-2027) & (Kg)
Table 106. Global Levonorgestrel API Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Levonorgestrel API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Levonorgestrel API Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Levonorgestrel API Sales Forecast by Region (2022-2027) & (Kg)
Table 110. Global Levonorgestrel API Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Levonorgestrel API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Levonorgestrel API Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Levonorgestrel API
Figure 2. Global Levonorgestrel API Market Share by Type in 2020 & 2027
Figure 3. Short-Acting Contraceptive API Product Picture
Figure 4. Long-Acting Contraceptive API Product Picture
Figure 5. Global Levonorgestrel API Market Share by Application in 2020 & 2027
Figure 6. Levonorgestrel Tablet
Figure 7. Mixture Products
Figure 8. Hormone-releasing IUD
Figure 9. Global Levonorgestrel API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Levonorgestrel API Market Size 2016-2027 (US$ Million)
Figure 11. Global Levonorgestrel API Sales 2016-2027 (Kg)
Figure 12. Global Levonorgestrel API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Levonorgestrel API Sales Share by Manufacturers in 2020
Figure 14. Global Levonorgestrel API Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Levonorgestrel API Players: Market Share by Revenue in 2020
Figure 16. Levonorgestrel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Levonorgestrel API Sales Market Share by Region (2016-2021)
Figure 18. Global Levonorgestrel API Sales Market Share by Region in 2020
Figure 19. Global Levonorgestrel API Revenue Market Share by Region (2016-2021)
Figure 20. Global Levonorgestrel API Revenue Market Share by Region in 2020
Figure 21. U.S. Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Levonorgestrel API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Levonorgestrel API by Type (2016-2021)
Figure 44. Sales Market Share of Levonorgestrel API by Application (2016-2021)
Figure 45. Sales Market Share of Levonorgestrel API by Application in 2020
Figure 46. Revenue Share of Levonorgestrel API by Application (2016-2021)
Figure 47. Revenue Share of Levonorgestrel API by Application in 2020
Figure 48. Manufacturing Cost Structure of Levonorgestrel API
Figure 49. Manufacturing Process Analysis of Levonorgestrel API
Figure 50. Levonorgestrel API Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed